Corvus Pharmaceuticals Inc (CRVS)
8.935
+0.70
(+8.43%)
USD |
NASDAQ |
Nov 21, 16:00
8.90
-0.04
(-0.39%)
After-Hours: 19:20
Corvus Pharmaceuticals Price: 8.935 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 8.34 | 8.39 | 8.02 | 8.24 | 525398.0 |
Nov 19, 2024 | 8.17 | 8.61 | 8.16 | 8.40 | 808659.0 |
Nov 18, 2024 | 8.26 | 8.71 | 8.16 | 8.34 | 637022.0 |
Nov 15, 2024 | 8.40 | 8.51 | 7.78 | 8.19 | 2.349M |
Nov 14, 2024 | 8.94 | 9.00 | 7.89 | 8.52 | 1.219M |
Nov 13, 2024 | 9.96 | 10.00 | 8.79 | 8.87 | 1.273M |
Nov 12, 2024 | 9.40 | 9.70 | 8.67 | 8.69 | 673929.0 |
Nov 11, 2024 | 9.63 | 9.90 | 9.28 | 9.56 | 574553.0 |
Nov 08, 2024 | 8.71 | 9.61 | 8.62 | 9.45 | 754623.0 |
Nov 07, 2024 | 8.67 | 9.10 | 8.43 | 8.80 | 1.083M |
Nov 06, 2024 | 9.66 | 9.70 | 8.50 | 8.78 | 1.634M |
Nov 05, 2024 | 8.93 | 9.44 | 8.87 | 9.23 | 1.069M |
Nov 04, 2024 | 8.99 | 9.37 | 7.91 | 9.02 | 1.391M |
Nov 01, 2024 | 8.945 | 9.28 | 8.82 | 9.10 | 655845.0 |
Oct 31, 2024 | 8.66 | 9.025 | 8.51 | 8.84 | 539689.0 |
Oct 30, 2024 | 9.00 | 9.19 | 8.55 | 8.80 | 734333.0 |
Oct 29, 2024 | 8.61 | 8.96 | 8.45 | 8.89 | 641138.0 |
Oct 28, 2024 | 8.65 | 9.08 | 8.51 | 8.64 | 1.858M |
Oct 25, 2024 | 7.78 | 8.686 | 7.74 | 8.31 | 1.619M |
Oct 24, 2024 | 7.64 | 8.18 | 7.57 | 7.68 | 1.309M |
Oct 23, 2024 | 7.69 | 7.83 | 7.03 | 7.56 | 1.055M |
Oct 22, 2024 | 7.79 | 8.33 | 7.56 | 7.75 | 1.573M |
Oct 21, 2024 | 7.15 | 7.72 | 6.93 | 7.56 | 480333.0 |
Oct 18, 2024 | 7.11 | 7.64 | 7.10 | 7.21 | 612829.0 |
Oct 17, 2024 | 7.36 | 7.54 | 7.14 | 7.21 | 837492.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.6481
Minimum
Mar 28 2023
9.56
Maximum
Nov 11 2024
2.672
Average
2.28
Median
Mar 07 2024
Price Benchmarks
Azenta Inc | 45.54 |
Perspective Therapeutics Inc | 2.99 |
Atara Biotherapeutics Inc | 10.60 |
Clearside Biomedical Inc | 1.03 |
Quanterix Corp | 11.72 |
Price Related Metrics
Price to Book Value | 46.27 |
Earnings Yield | -10.30% |
Market Cap | 574.14M |